PDTM-19. TUMOUR TREATING FIELDS (TTFIELDS) EXHIBIT EFFICACY ON HIGH-GRADE PAEDIATRIC BRAIN TUMOUR CELL LINES

Por Branter, Joshua, Estevez Cebrero, Maria de los Angeles, Grundy, Richard, Basu, Surajit, Smith, Stuart
Publicado no Neuro Oncol (2018)

P10.05 Periodic assessment with optical coherence tomography in children treated with multimodal therapies for brain tumors

Por Bacci, G. M., Ghin, M., Lucchesi, M., Guidi, M., Ferraro, M., Farina, S., Favre, C., Genitori, L., Caputo, R., Sardi, I.
Publicado no Neuro Oncol (2016)

Tumour Treating Fields (TTFields) have anti-proliferative effects on paediatric brain tumour cell lines at clinically deliverable field settings

Por Branter, Joshua, de los Angeles Estevez-Cebrero, Maria, Grundy, Richard, Basu, Surajit, Smith, Stuart
Publicado no Neuro Oncol (2018)

Frequency, clinical correlates and rating of behavioural changes in primary brain tumour patients: A preliminary investigation.

Por Grahame K Simpson, Grahame K Simpson, Eng-Siew eKoh, Eng-Siew eKoh, Eng-Siew eKoh, Diane eWhiting, Kylie M Wright, Kylie M Wright, Teresa eSimpson, Teresa eSimpson, Rochelle eFirth, Lauren eGillett, Kathryn eYounan
Publicado em 2015-04-01

P02.14 Tumour Treating Fields (TTFields) demonstrate variable efficacy on high-grade paediatric brain tumour cell lines in a frequency-dependent manner

Por Branter, J, Estevez Cebrero, M, Grundy, R, Basu, S, Smith, S
Publicado no Neuro Oncol (2018)

PP79. DIAGNOSIS TO TREATMENT TIME FOR BRAIN TUMOURS: AUDIT

Por Umotong, Dr Eno
Publicado no Neuro Oncol (2017)

OP17. Measuring and modifying Temozolomide delivery in brain tumours

Por Djoukhadar, Dr Ibrahim, Asselin, Dr Marie-claude, Williams, Prof Kaye, Jackson, Prof Alan
Publicado no Neuro Oncol (2017)

Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

Por Brada, M., Ford, D., Ashley, S., Bliss, J. M., Crowley, S., Mason, M., Rajan, B., Traish, D.
Publicado em 1992

CLINICALLY DELIVERABLE OPTUNE AND DEEP BRAIN STIMULATOR GENERATED ELECTRICAL FIELDS HAVE VARIABLE EFFICACY ON DIFFERENT TYPES OF BRAIN TUMOUR

Por Branter, Joshua, de los Angeles Estevez-Cebrero, Maria, Grundy, Richard, Basu, Surajit, Smith, Stuart
Publicado no Neuro Oncol (2018)

PP31. A SYSTEMATIC REVIEW OF THE EFFECT OF CASELOAD ON OUTCOMES IN BRAIN TUMOUR SURGERY

Por Wan, Mr Yizhou, Hassan, Dr Syed
Publicado no Neuro Oncol (2017)

Effect of polyamine depletion on chromatin structure in U-87 MG human brain tumour cells.

Por Basu, H S, Sturkenboom, M C, Delcros, J G, Csokan, P P, Szollosi, J, Feuerstein, B G, Marton, L J
Publicado em 1992

Spontaneous haemorrhage into metastatic brain tumours after stereotactic radiosurgery using a linear accelerator

Por Suzuki, H, Toyoda, S, Muramatsu, M, Shimizu, T, Kojima, T, Taki, W
Publicado em 2003

Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modelling

Por Baliga, Sujith, Garg, Madhur K, Fox, Jana, Kalnicki, Shalom, Lasala, Patrick A, Welch, Mary R, Tomé, Wolfgang A, Ohri, Nitin
Publicado no Br J Radiol (2017)

Growth hormone and tumour recurrence.

Por Ogilvy-Stuart, A. L., Ryder, W. D., Gattamaneni, H. R., Clayton, P. E., Shalet, S. M.
Publicado em 1992

Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion

Por Yen, S-Y, Chen, S-R, Hsieh, J, Li, Y-S, Chuang, S-E, Chuang, H-M, Huang, M-H, Lin, S-Z, Harn, H-J, Chiou, T-W
Publicado no Oncogene (2016)

PP66. OUTCOMES OF HIGH GRADE GLIOMA PATIENTS TREATED WITH TWO DIFFERENT RADIOTHERAPY REGIMES...

Por Yim, Mr Justin, Howell, Ms Laura, Kumar, Dr Varadarajan, Kennedy, Dr Stephen R
Publicado no Neuro Oncol (2017)

Visual pathway glioma: an erratic tumour with therapeutic dilemmas

Por Shuper, A, Horev, G, Kornreich, L, Michowiz, S, Weitz, R, Zaizov, R, Cohen, I
Publicado em 1997

Is cell survival a determinant of the in situ response of 9L tumours?

Por Wheeler, K. T., Wallen, C. A.
Publicado em 1980

Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry.

Por Riccardi, A., Danova, M., Dionigi, P., Gaetani, P., Cebrelli, T., Butti, G., Mazzini, G., Wilson, G.
Publicado em 1989

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial

Por Zindler, Jaap D., Bruynzeel, Anna M. E., Eekers, Daniëlle B. P., Hurkmans, Coen W., Swinnen, Ans, Lambin, Philippe
Publicado no BMC Cancer (2017)